ADA Scientific Sessions 2026 Abstract
Mazdutide vs. Semaglutide in Chinese Adults with Type 2 Diabetes and Obesity (DREAMS-3): A Randomised, Open-Label, Phase 3b Trial
Trial in peopleInterventions
Papers by Yingying Luo
7 results
- ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of DA-302168S, a Novel Oral GLP-1 Receptor Agonist, in Chinese Adults with Overweight or Obesity: A Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Long-Term Safety and Efficacy of HTD1801 in Patients with Type 2 Diabetes: Two Phase 3 Open-Label Extensions
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Bidirectional Association between Obesity and Urinary Albumin–Creatinine Ratio: Cortisol as a Key Mediator with Gender-Specific Effects
Study in peoplePopulations
- ADA Scientific Sessions 2025 Abstract
Meta-analysis of hsCRP's Effect on Cardiovascular Outcome among GLP-1RAs–Based Clinical Trials
ReviewInterventions - ADA Scientific Sessions 2025 Abstract
Comparing Models for Predicting Diabetes Progression and Cardiovascular Disease in Risk Stratification and Drug Selection for Prediabetes
Trial in peopleBiomarkers - ADA Scientific Sessions 2025 Abstract
Exploring the European Association for the Study of Obesity (EASO) Criteria for Identifying Abdominal Visceral Fat Accumulation in the Chinese Population
Study in peopleBiomarkers